Publications
See a complete PubMed list of publications by Qiang Wang, PhD.
Selected Key Publications
- Morvaridi S, Dhall D, Greene MI, Pandol SJ, Wang Q. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci. Rep. 2015;5:16759. http://www.nature.com/articles/srep16759.
- Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, et al. FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer. Cell Rep. 2015;13(5):1046-1058. http://www.cell.com/cell-reports/abstract/S2211-1247(15)01105-5.
- Taylor-Harding B, Aspuria PJ, Agadjanian H, Cheon DJ, Mizuno T, Greenberg D, Allen JR, Spurka L, Funari V, Spiteri E, Wang Q, et al. Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS. Oncotarget. 2015 Jan 20;6(2):696-714. http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=2673.
- Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Berezov A, Zhang H, Karlan B, Greene MI, Wang Q. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene. 2013;32(17):2220-2229. http://www.nature.com/onc/journal/v32/n17/full/onc2012231a.html.
- Runkle EA, Zhang H, Cai Z, Zhu Z, Karger BL, Wu SL, O’Rorke DM, Zhou Z, Wang Q, Greene MI. Reversion of the ErbB malignant phenotype and the DNA damage response. Exp Mol Pathol. 2012 Dec;93(3):324-333. http://www.sciencedirect.com/science/article/pii/S0014480012001293.
- Wang W, Shi Z, Jiao S, Chen C, Wang H, Liu G, Wang Q, Zhao Y, Greene MI, Zhou Z. Structural insights into SUN-KASH complexes across the nuclear envelope. Cell Res. 2012 Oct;22(10):1440-1452. http://www.nature.com/cr/journal/v22/n10/full/cr2012126a.html.
- Song X, Li B, Xiao Y, Chen C, Wang Q, Liu Y, Berezov A, Xu C, Gao Y, Li Z, et al. Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep. 2012;1(6):665-675. http://www.cell.com/cell-reports/abstract/S2211-1247(12)00132-5.
- Berezov A, Freudenberg JA, Cai Z, Zhang H, Thompson T, Murali R, Greene MI, Wang Q. Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin. Oncogene. 2012;31(15):1938-1948. http://www.nature.com/onc/journal/v31/n15/full/onc2011377a.html.
- McKie AB, Vaughan S, Zanini E, Okon I, Louis L, de Sousa C, Greene MI, Wang Q, Shaposhnikov D, et al. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer with therapeutic implications. Cancer Discov. 2012;2(2):156-171. https://aacrjournals.org/cancerdiscovery/article/2/2/156/3071/The-OPCML-Tumor-Suppressor-Functions-as-a-Cell
- Zhou Z, Du X, Cai Z, Song X, Zhang H, Mizuno T, Suzuki E, Yee MR, Berezov A, Murali R, Wu SL, Karger BL, Greene MI, Wang Q. Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope. J Biol Chem. 2012 Feb 17;287(8):5317-5326. http://www.jbc.org/content/287/8/5317.
- Zhang G, Zhang H, Wang Q, Lal P, Carroll AM, de la Llera-Moya M, Xu X, Greene MI. Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker. Proc Natl Acad Sci USA. 2010;107(2):732-737. http://www.pnas.org/content/107/2/732.
- Liu Q, Hirohashi Y, Greene MI, Wang Q. Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20. Exp Mol Pathol. 2010;88(2):225-233. http://www.sciencedirect.com/science/article/pii/S0014480009001701.
Contact the Q. Wang Lab
8700 Beverly Blvd.
Davis Building, Room 3098
Los Angeles, California 90048